NEW MJ NEWS

Cara Therapeutics to Present at the Jefferies Healthcare Conference

Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023, at 3 p.m. EDT in New York, NY.

A webcast of the presentation can be accessed under “Events & Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus. The Company’s KORSUVA® (difelikefalin) injection is the first and only FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. The Company is developing an oral formulation of difelikefalin and has Phase 3 programs ongoing for the treatment of pruritus in patients with non-dialysis dependent advanced chronic kidney disease and atopic dermatitis. In addition, the Company has initiated a Phase 2/3 program of oral difelikefalin for the treatment of moderate-to-severe pruritus in patients with notalgia paresthetica. For more information, visit www.CaraTherapeutics.com and follow the company on Twitter, LinkedIn and Instagram.

MEDIA CONTACT:
Annie Spinetta
6 Degrees
973-768-2170
aspinetta@6degreespr.com

INVESTOR CONTACT:
Iris Francesconi, Ph.D.
Cara Therapeutics
203-406-3700
investor@caratherapeutics.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MJNA Announces Settlement of Major Pending Litigation With CannaVest

Medical Marijuana, Inc. Announces Settlement of Major Pending Litigation With CannaVest and…

 Novus Acquisition and Development, Corp. (NDEV) MedPlan Reports 2019 Earnings Results

Novus Cannabis MedPlan Reports 2019 Earnings Results  Novus Acquisition and Development, Corp.…

CLS Holdings USA Inc. (CLSH) Acquisition Target ‘In Good Health’ Announces it has Entered into a Host Agreement with the Town of Sandwich

CLS Holdings’ Acquisition Target ‘In Good Health’ Announces it has Entered into…

GT Biopharma Inc. (GTBP) Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare Conference

GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at…